Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: A Report of the AAPM TG‐203†
Medical Physics2019Vol. 46(12), pp. e757–e788
Citations Over TimeTop 1% of 2019 papers
Moyed Miften, D Mihailidis, Stephen F. Kry, Chester S. Reft, C Esquivel, Jonathan B. Farr, D Followill, Coen Hurkmans, Arthur Liu, Olivier Gayou, Michael S. Gossman, Mahadevappa Mahesh, Richard A. Popple, Joann I. Prisciandaro, Jeff Wilkinson
Abstract
Managing radiotherapy patients with implanted cardiac devices (implantable cardiac pacemakers and implantable cardioverter-defibrillators) has been a great practical and procedural challenge in radiation oncology practice. Since the publication of the AAPM TG-34 in 1994, large bodies of literature and case reports have been published about different kinds of radiation effects on modern technology implantable cardiac devices and patient management before, during, and after radiotherapy. This task group report provides the framework that analyzes the potential failure modes of these devices and lays out the methodology for patient management in a comprehensive and concise way, in every step of the entire radiotherapy process.
Related Papers
- → Implementation of Device Therapy (Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator) for Patients with Heart Failure in Europe: Changes from 2004 to 2008(2009)133 cited
- → Radiation Oncology: A Physicist's-Eye View(2007)66 cited
- → One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator(2021)3 cited
- → Improving Patient Care in Radiation Oncology: Redefining the Role of the Clinical Medical Physicist(2021)1 cited
- → The Chief Information Technology Officer in a Radiation Oncology department should be a medical physicist(2009)1 cited